Global airway management provider presents innovative technology to
address common challenges in clinical practice
Innovative LMA® Products designed to give
physicians confidence to expand usage of laryngeal masks into additional
procedures
WAYNE, Pa.--(BUSINESS WIRE)--Oct. 19, 2016--
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical
technologies for critical care and surgery, has a rich history of
innovation focused on solving unmet clinical needs. Recent product
introductions under the LMA® brand from Teleflex focus on
giving the physician enhanced control of the airway throughout the use
of anesthetic. Teleflex is scheduled to showcase this innovative
technology at the upcoming ANESTHESIOLOGY® 2016, the annual
organization meeting of the American Society of Anesthesiologists®
(ASA).
“Teleflex is proud of our heritage as an innovator in the field of
anesthesia,” said Justin McMurray, President of the Teleflex Anesthesia
& Emergency Medicine Division. “Our LMA brand helped set the
standard of care for airway management and we are excited to continue
this tradition with the introduction of new technology and quality
education that empower clinicians to achieve airway control.”
Cuff Pressure Control:
Numerous scientific papers have highlighted the need to monitor and
control cuff pressures in laryngeal masks to reduce the risks of patient
trauma and airway leakage.1-3 Despite this evidence,
manometry is not routinely used to determine cuff pressure during
placement of a laryngeal mask or to monitor changes in cuff pressure
during a procedure.1,3,4 Instead, clinicians often judge this
by the 'feel' of the distension of the pilot valve.
The continuous control of intracuff pressure through in-line (or
integrated) cuff pressure monitoring has been clinically shown to reduce
the risk of patient trauma or leaks.4,5 Cuff Pilot™
Technology from Teleflex constantly monitors the pressure in the cuff to
detect changes resulting from fluctuations in temperature, nitrous oxide
levels and movements within the airway. This provides clinicians with
at-a-glance feedback, highlighting changes that could affect patient
safety. The pressure levels are color-coded to indicate whether the cuff
is at optimal pressure (green), under-inflated (yellow) or over-inflated
(red). Teleflex has made Cuff Pilot™ Technology a standard feature on
several single-use LMA® Airway products, including the LMA®
Protector™ Airway, LMA® Unique™ (Silicone
Cuff) Airway and the LMA® Gastro™ Airway.
Advanced Airway Control:
Establishing adequate controlled ventilation and avoiding air leaks
during anesthesia is of utmost concern to clinicians.6 Failed
ventilation can sabotage the anesthetic, impact patient safety with
consequent hypoventilation, increase risk of gastric inflation and may
add cost and complexity to procedures.6
The LMA® Protector™ Airway from Teleflex combines
the latest innovations in LMA® Airway design to help
clinicians achieve advanced airway control. The elongated silicone cuff
is designed to support seal pressures of >30 cm H20,
enabling broad clinical usage, while the distal tip facilitates a secure
seal with the upper esophageal sphincter to isolate the respiratory
tract from the digestive tract and help reduce the risk of aspiration of
gastric contents. This second-generation laryngeal mask has an
integrated drain tube that supports diagnostic testing to verify mask
positioning, and is equipped with Cuff Pilot™ Technology, providing
continuous cuff pressure monitoring throughout the procedure.
The LMA® Protector™ Airway features a silicone airway tube
with a dynamic fixed curve, designed to enable rapid insertion and a
secure fit. In addition, it supports direct intubation under vision for
effective airway replacement. In the unlikely event of regurgitation,
the LMA® Protector™ Airway is equipped with a proprietary
dual gastric drainage channel and pharyngeal chamber designed
specifically to channel high-volume, high-pressure gastric contents away
from the airway.
Potential uses for the LMA® Protector™ Airway include:
-
More difficult cases where an endotracheal tube may otherwise be used,
such as for patients with controlled Gastroesophageal Reflux Disease
(GERD)
-
Cases for which Positive Pressure Ventilation (PPV) may be required
Airway Control during Endoscopic Procedures
The use of moderate to deep sedation during endoscopy is a common
practice around the world. Respiratory depression from sedative drugs
and airway obstruction requiring intervention are known risks associated
with endoscopic procedures, with studies demonstrating that hypoxemia
can occur in 11–50% of cases.7-9 In the United States there
are more than 6.9 million upper endoscopies performed per year.10
Today, many of these are undertaken without an airway management device
in place.
The new LMA® GastroTM Airway with Cuff Pilot™
Technology is the only laryngeal mask specifically designed to help
clinicians gain control of a patient’s airway while facilitating direct
endoscopic access via the integrated endoscope channel. Indicated for
airway management in adult patients undergoing endoscopic procedures,
the LMA® Gastro™ Airway maintains a patent airway and allows
clinicians to monitor end tidal CO2, advancing patient safety
during endoscopic procedures. It also has an integral bite block to
reduce the potential for damage to the endoscope due to biting, helping
to avoid costly repairs.
Teleflex Academy
During the ANESTHESIOLOGY® 2016 annual meeting in Chicago,
Teleflex will offer in-booth education powered by ‘Teleflex Academy’.
Training will focus on a range of aspects of airway control, inspiring
confidence, enhancing skills and empowering clinicians to advance
anesthesia practice.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
American Society of Anesthesiologists, ASA, and ANESTHESIOLOGY are
trademarks or registered trademarks of American Society of
Anesthesiologists (ASA).
Teleflex, the Teleflex logo, Arrow, Cuff Pilot, Deknatel, Hudson RCI,
LMA, LMA Gastro, LMA Protector, LMA Unique, Pilling, Rusch and Weck are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other countries.
© 2016 Teleflex Incorporated. All rights reserved. MC-002748
References:
1. Bick E, Bailes I, Patel A, Brain AI. Fewer sore throats and a better
seal: why routine manometry for laryngeal mask airways must become the
standard of care. Anaesthesia. 2014;69(12):1304-1308.
2.Burgard
G, Mollhoff T, Prien T. The effect of laryngeal mask cuff pressure on
postoperative sore throat incidence. J Clin Anesth.
1996;8(3):198-201.
3.Seet E, Yousaf F, Gupta S, Subramanyam R, Wong
DT, Chung F. Use of manometry for laryngeal mask airway reduces
postoperative pharyngolaryngeal adverse events: a prospective,
randomized trial. Anesthesiology. 2010;112(3):652-657.
4.Wong
DT, Tam AD, Mehta V, Raveendran R, Riad W, Chung FF. New supraglottic
airway with built-in pressure indicator decreases postoperative
pharyngolaryngeal symptoms: a randomized controlled trial. Can J
Anaesth. 2013;60(12):1197-1203.
5.Martin DP, Bhalla T, Thung A,
Tobias JD. Clinical evaluation of a novel LMA with a color-coded
pressure gauge. Int J Pediatr Otorhinolaryngol. 2013;77(1):76-78.
6.Cook
TM, MacDougall-Davis SR. Complications and failure of airway management. Br
J Anaesth. 2012;109 Suppl 1:i68-i85.
7.Cote GA, Hovis RM,
Ansstas MA, et al. Incidence of sedation-related complications with
propofol use during advanced endoscopic procedures. Clin
Gastroenterol Hepatol. 2010;8(2):137-142.
8.Qadeer MA, Rocio
Lopez A, Dumot JA, Vargo JJ. Risk factors for hypoxemia during
ambulatory gastrointestinal endoscopy in ASA I-II patients. Dig Dis
Sci. 2009;54(5):1035-1040.
9.de Paulo GA, Martins FP, Macedo
EP, Goncalves ME, Mourao CA, Ferrari AP. Sedation in gastrointestinal
endoscopy: a prospective study comparing
nonanesthesiologist-administered propofol and monitored anesthesia care. Endosc
Int Open. 2015;3(1):E7-E13.
10.Peery AF, Dellon ES, Lund J, et
al. Burden of gastrointestinal disease in the United States: 2012
update. Gastroenterology. 2012;143(5):1179-1187 e1-3.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161019005023/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836